NS
NanoSphere Health Sciences Inc.
NSHSF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $102.8K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.02
100.0% upside
Current Price
$0.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NSHSF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
0/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
43 /100
Average ROA 513.06%
Asset turnover 0.00x
ROIC 14.09%
Debt
0 /100
High Int. coverage -42.64x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 172.51%
Profitable years 0
Beta 0.71x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NSHSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Alexander Iverson
Employees
3
Headquarters
Vancouver